MA45283B1 - A COMPOSITION OF MULTIVALENT PNEUMOCOCCAL POLYSACCARID-CAPSULAR CARRIER PROTEIN COMBINES AND USE FROM THIS - Google Patents

A COMPOSITION OF MULTIVALENT PNEUMOCOCCAL POLYSACCARID-CAPSULAR CARRIER PROTEIN COMBINES AND USE FROM THIS

Info

Publication number
MA45283B1
MA45283B1 MA45283A MA45283A MA45283B1 MA 45283 B1 MA45283 B1 MA 45283B1 MA 45283 A MA45283 A MA 45283A MA 45283 A MA45283 A MA 45283A MA 45283 B1 MA45283 B1 MA 45283B1
Authority
MA
Morocco
Prior art keywords
composition
polysaccarid
carrier protein
multivalent pneumococcal
protein combines
Prior art date
Application number
MA45283A
Other languages
French (fr)
Other versions
MA45283A1 (en
Inventor
Tae Hyun Kim
Hoon Sung Jeh
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of MA45283A1 publication Critical patent/MA45283A1/en
Publication of MA45283B1 publication Critical patent/MA45283B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une composition de vaccin comprenant 13 ou 14 types de conjugués de protéine de transport de polysaccharide capsulaire pour la prévention de maladies à pneumocoque et une composition immunogène pour streptococcus pneumoniae.The present invention relates to a vaccine composition comprising 13 or 14 types of capsular polysaccharide transport protein conjugates for the prevention of pneumococcal disease and an immunogenic composition for streptococcus pneumoniae.

MA45283A 2016-09-06 2017-08-31 A COMPOSITION OF MULTIVALENT PNEUMOCOCCAL POLYSACCARID-CAPSULAR CARRIER PROTEIN COMBINES AND USE FROM THIS MA45283B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160114591 2016-09-06
PCT/KR2017/009569 WO2018048141A1 (en) 2016-09-06 2017-08-31 Composition comprising multivalent capsular polysaccharide-transport protein and use thereof

Publications (2)

Publication Number Publication Date
MA45283A1 MA45283A1 (en) 2019-06-28
MA45283B1 true MA45283B1 (en) 2021-05-31

Family

ID=61561397

Family Applications (1)

Application Number Title Priority Date Filing Date
MA45283A MA45283B1 (en) 2016-09-06 2017-08-31 A COMPOSITION OF MULTIVALENT PNEUMOCOCCAL POLYSACCARID-CAPSULAR CARRIER PROTEIN COMBINES AND USE FROM THIS

Country Status (12)

Country Link
KR (1) KR101991457B1 (en)
BR (1) BR112019004303A2 (en)
EA (1) EA201990451A1 (en)
JO (1) JOP20190038B1 (en)
MA (1) MA45283B1 (en)
MX (1) MX2019002552A (en)
MY (1) MY192792A (en)
PH (1) PH12019500377A1 (en)
SA (1) SA519401232B1 (en)
TN (1) TN2019000064A1 (en)
WO (1) WO2018048141A1 (en)
ZA (1) ZA201901969B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3720483A2 (en) 2017-12-06 2020-10-14 Merck Sharp&Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
IL304977A (en) 2018-02-05 2023-10-01 Sanofi Pasteur Inc Multivalent pneumococcal polysaccharide-protein conjugate composition
BR112020021296A2 (en) 2018-04-18 2021-01-26 Sk Bioscience Co., Ltd. capsular polysaccharide of streptococcus pneumoniae and its immunogenic conjugate
CR20210333A (en) 2018-12-19 2021-08-18 Merck Sharp & Dohme Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
WO2023218322A1 (en) * 2022-05-11 2023-11-16 Pfizer Inc. Process for producing of vaccine formulations with preservatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3828145B2 (en) * 1993-09-22 2006-10-04 ヘンリー エム．ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン A method for the activation of soluble carbohydrates using a novel cyanating reagent for the production of immunogenic components
CN104815327A (en) * 2005-04-08 2015-08-05 惠氏有限责任公司 Multivalent pneumococcal polysaccharide-protein conjugate composition
HUE048398T2 (en) * 2010-06-04 2020-07-28 Wyeth Llc Vaccine formulations
KR102057217B1 (en) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 Multivalent pneumococcal polysaccharide-protein conjugate composition
CN103893751B (en) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 A kind of pneumococal polysaccharide Protein Conjugation vaccine and preparation method thereof
CN104069504B (en) * 2014-05-11 2019-09-24 江苏康泰生物医学技术有限公司 A method of enhancing polysaccharide protein conjugate immunogenicity

Also Published As

Publication number Publication date
SA519401232B1 (en) 2022-10-23
MX2019002552A (en) 2019-07-01
PH12019500377A1 (en) 2019-10-21
KR20180027353A (en) 2018-03-14
MY192792A (en) 2022-09-09
TN2019000064A1 (en) 2020-07-15
WO2018048141A1 (en) 2018-03-15
BR112019004303A2 (en) 2019-05-28
KR101991457B1 (en) 2019-09-30
JOP20190038B1 (en) 2023-09-17
ZA201901969B (en) 2019-12-18
EA201990451A1 (en) 2019-08-30
MA45283A1 (en) 2019-06-28
JOP20190038A1 (en) 2019-03-06

Similar Documents

Publication Publication Date Title
MA45283B1 (en) A COMPOSITION OF MULTIVALENT PNEUMOCOCCAL POLYSACCARID-CAPSULAR CARRIER PROTEIN COMBINES AND USE FROM THIS
PH12021550318A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CY1123783T1 (en) ENANTI-B7-H3 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
PH12018500037A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
MX2023001947A (en) Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates.
BR112020004471A8 (en) PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
BR112020004396A8 (en) PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
MX2022009928A (en) Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates.
BR112016016580A2 (en) CAPSULAR POLYSACCHARIDES FROM STREPTOCOCCUS PNEUMONIAE AND CONJUGATES THEREOF
MX2018015285A (en) Anti-b7-h3 antibodies and antibody drug conjugates.
MX2018015277A (en) Anti-b7-h3 antibodies and antibody drug conjugates.
MX2016003621A (en) Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3.
EA202091690A1 (en) IMMUNOGENIC COMPOSITION CONTAINING STAPHYLOCOCCAL ANTIGENS
MX2018008300A (en) Formulation for antibody and drug conjugate thereof.
CO2021007863A2 (en) Multivalent pneumococcal polysaccharide-protein conjugate vaccine
WO2016198170A8 (en) Vaccines against streptococcus pneumoniae serotype 5
MX2022001937A (en) Immunogenic composition.